David P. Southwell, Director at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 150,000 shares at $24.22 ($3.7M) on 2024-04-12, disclosed to the SEC on 2024-04-16.
Open-market sale of $3.7M RCKT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.22 | 59,716 | $1.4M | 39.6% |
| 2 | $24.22 | 59,716 | $1.4M | 39.6% |
| 3 | $25.16 | 10,284 | $259K | 7.1% |
| 4 | $25.16 | 10,284 | $259K | 7.1% |
| 5 | $24.05 | 10,000 | $241K | 6.6% |
| Total | $24.34 avg | 150,000 |
| $3.7M |
| 100% |
| Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |
| TCRX | BUY | 2022-05-20 | $90K | — | Filing → |